2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow raltitrexed: new trials by email Literature Review of raltitrexed trials Research Report on raltitrexed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma Gefitinib, raltitrexed - Colorectal Cancer | Phase 2 / Phase 3 | Completed | AstraZeneca | 74 | 2003-11-01 | 2007-12-18 |
| Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura cisplatin, raltitrexed - Malignant Mesothelioma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 256 | 1999-11-01 | 2012-07-18 |
Colorectal Neoplasms (1) · Mesothelioma, Malignant (1)
AstraZeneca (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Belgium (1) · Canada (1) · Egypt (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Peru (1) · Poland (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Jan P. Van Meerbeeck, MD, PhD (1)
PMID 16192580, PMID 16446322, PMID 18089874, PMID 32645159, PMID 35235653, PMID 36101518